Introduction
Hematopoietic stem cells (HSC) are ideal targets of gene therapy for many disorders because of their self-renewal and multilineage differentiation ability.
1,2 Once a therapeutic gene is integrated into the genome of HSC, the transgene is maintained through cell divisions and longterm expression can be expected. Retroviral vectors are most commonly used for this purpose and the stable existence and expression of transgenes have been established in mice. However, currently available vectors suffer from low efficiency of gene transfer into human HSC and therefore most clinical trials of stem cell gene therapy have resulted in minimal therapeutic benefits. [2] [3] [4] To overcome this problem, we have developed 'selective amplifier genes' to expand genetically modified cells upon exogenous stimuli. We previously constructed a prototype selective amplifier gene encoding a fusion protein (GCRER) containing the full-length mouse granulocyte colony-stimulating factor receptor (G-CSFR) and the hormone-binding domain (HBD) of the rat estrogen receptor (ER). 5 In this chimera, the G-CSFR portion was employed to generate a growth signal analogous to that produced by the native receptor upon binding of granulocyte colony-stimulating factor (G-CSF) and ER-HBD to act as a molecular switch to regulate the activity of G-CSFR in an estrogen-dependent manner. [6] [7] [8] As expected, estrogen as well as G-CSF stimulated the proliferation of hematopoietic cells expressing GCRER. We also demonstrated that its derivative ⌬GCRER, in which the G-CSFbinding domain was deleted, conferred responsiveness to estrogen on the transduced cells while the modified molecule was no longer activated by G-CSF.
However, the above selective amplifier gene products transmitted both growth and differentiation signals when activated by estrogen. When ⌬GCRER was expressed in interleukin-3 (IL-3)-dependent Ba/F3, estrogen supported continuous growth of the cells without IL-3. On the other hand, expression of ⌬GCRER in 32Dcl3, another IL-3-dependent cell line, resulted in a different phenotype. Similar to G-CSF-induced granulocytic differentiation in wild-type 32Dcl3, the estrogen-induced growth of the derivative cells gradually subsided along with morphological maturation. If we can manipulate ⌬GCRER to transmit a growth signal alone in a controllable manner, this system will become useful for stem cell expansion.
This prompted us to modify the existing selective amplifier gene to attenuate the signal for granulocytic differentiation. The cytoplasmic region of G-CSFR has been dissected into several functional domains for transmitting multiple signals. [9] [10] [11] In mouse G-CSFR, the C-terminal half of the cytoplasmic region contains four tyrosine residues, of which the most proximal (tyrosine-703) was suggested to play an essential role in granulocytic differentiation. 12 We assessed whether mutation of the corresponding tyrosine in ⌬GCRER could stimulate proliferation of the gene-modified hematopoietic cells while suppressing differentiation.
Results

Construction of selective amplifier genes
The structures of the G-CSFR/ER-HBD chimeric molecules are depicted in Figure 1 . GCRER is a prototype of the selective amplifier genes, encoding a fusion protein of the full-length mouse G-CSFR and the rat ER-HBD. 13, 14 In ⌬GCRER, the G-CSF-binding domain (amino acids in the full-length G-CSFR) was deleted to eliminate G-CSF-induced activation and this molecule transmitted an estrogen-specific growth signal. 5 In ⌬Y703F-GCRER, phenylalanine was substituted for a cytoplasmic tyrosine (corresponding to position 703 in the murine G-CSFR), based on the results of mutation analysis by Yoshikawa et al. 12 In the present study, ⌬GCRER and ⌬Y703F-GCRER cDNAs were cloned into bicistronic retroviral vectors harboring the murine CD8a gene downstream of the encephalomyocarditis virus (EMCV)-derived internal ribosome entry site (IRES). [15] [16] [17] As a result, each construct (pMX/⌬GCRER-IRES-CD8a or pMX/⌬Y703F-GCRER-IRES-CD8a) had one selective amplifier gene (⌬GCRER or ⌬Y703F-GCRER) to be expressed in a cap-dependent manner and CD8a to be IRES-dependent.
Morphology of 32D cells transduced with selective amplifier genes after stimulation by G-CSF or estrogen To evaluate the signaling properties of the chimeric receptors, we transduced a subline of 32Dcl3 cells with the selective amplifier genes. The original 32Dcl3 cells are mouse myeloid progenitors with differentiation potential. 18 They are usually supported by IL-3 for blastic growth, whereas G-CSF induces differentiation into morphologically mature neutrophils. Since the original 19 The MCAT-1-expressing cells (32D/MCAT) were readily transduced with ecotropic retroviruses and still underwent granulocytic differentiation upon switching from IL-3 to G-CSF with similar kinetics to the original 32Dcl3 (Figure 2a and b) . Therefore, 32D/MCAT cells were used in the following experiments, where they are simply described as 32D cells.
Transduction of 32D cells with MX/⌬GCRER-IRESCD8a and MX/⌬Y703F-GCRER-IRES-CD8a retroviruses resulted in CD8a-positive cells as demonstrated by fluorescence-activated cell sorting (FACS; data not shown). Subsequently, CD8a-positive cells were selected with immunomagnetic beads and FACS analysis showed that 97% of each selected population was CD8a-positive with 10-to 100-fold more fluorescence than control 32D. Several clones were randomly isolated from these cells by limiting dilution and the transgene was confirmed by polymerase chain reaction (PCR) to amplify a junctional fragment between G-CSFR and ER-HBD. 5 The PCR-confirmed cells were designated as 32D/⌬GCRER and 32D/⌬Y703F-GCRER, respectively, and incubated with 10 ng/ml recombinant human G-CSF or 10 −7 m ␤-estradiol (E 2 ). The dose of E 2 was chosen to support GCRER-and ⌬GCRER-expressing cells based on our previous observation. 5 Seven days later, we assessed granulocytic differentiation of the stimulated cells by Wright-Giemsa staining (Figure 2c-f), and the differential counts of the clones are summarized in Table 1 . In all the 32D/⌬GCRER clones, 60-70% of the cells were well-differentiated neu- 
Figure 2 Morphological characterization of 32D cells (Wright-Giemsa staining, × 400). (a) Parental 32D cells maintained with IL-3. (b) Day 7 32D cells with G-CSF. (c) Day 7 32D/⌬GCRER with G-CSF. (d) Day 7 32D/⌬GCRER with E 2 . (e) Day 7 32D/⌬Y703F-GCRER with G-CSF. (f) Day 7 32D/⌬Y703F-GCRER with E 2 . (g) 32D/⌬Y703F-GCRER cells were stimulated by G-CSF for 5 days following E 2 treatment for 7 days. (h, i) Longterm cultured 32D/⌬Y703F-GCRER cells with E 2 on day 15 (h) and day 30 (i).
32D cells were stained with Wright-Giemsa and examined on day 7 after G-CSF or ␤-estradiol (E 2 ) stimulation. 32D⌬Y703F-GCRER cells were also sequentially stimulated for 7 days by E 2 then 5 days by G-CSF. Differential counts of 32D/⌬GCRER and 32D/⌬Y703F-GCRER are represented as means ± s.d. Blast, myeloblasts; Promyel, promyelocytes; Myel, myelocytes; Metamyel, metamyelocytes; Neutrophil, mature neutrophils.
trophils regardless of whether they were stimulated by G-CSF or E 2 (Figure 2c and d) . On the other hand, E 2 -stimulated 32D/⌬Y703F-GCRER clones remained at immature stages analogous to myeloblasts or promyelocytes (Figure 2f ), whereas G-CSF induced terminal differentiation in these cells (Figure 2e ) as in untransduced and ⌬GCRER-transduced 32D cells. Although E 2 -stimulated 32D/⌬Y703F-GCRER cells were slightly differentiated as compared with those maintained with IL-3, they contained very few, if any, terminally differentiated neutrophils. The immature phenotype of 32D/⌬Y703F-GCRER was estrogen-dependent and reversible. When the E 2 -responsive 32D/⌬Y703F-GCRER cells were switched to G-CSF, they underwent granulocytic differentiation within 5 days (Figure 2g ). Typically 50-60% of the cells differentiated into neutrophils with an appearance indistinguishable from that of differentiated control 32D cells ( Table  1) , indicating that the endogenous G-CSFR signaling was preserved. That is, the transduced cells retained the differentiation potential which was transiently suppressed during estrogen treatment. We observed that the responses of 32D/⌬Y703F-GCRER cells to G-CSF tended to decrease slightly after longer E 2 20 This assay measures mitochondrial respiratory activity only present in viable cells, therefore the results are well correlated with the number of living cells. It is of note that the relatively small numbers of the starting cells in this study yielded very small A 490 -A 620 starting values in the XTT assay, which were almost in the background level. As shown in Figure 3a -c, all the 32D derivatives continued logarithmic growth with IL-3 (squares), while they died rapidly without growth factor support (diamonds; A 490 -A 620 curves appeared stationary, but the cells were actually dying off). In Figure 3c , the 32D/⌬Y703F-GCRER clone showed somewhat weaker growth response to IL-3 than the parental 32D and 32D/⌬GCRER cells, which may be due to clonal variation. When the stimulus was switched from IL-3 to G-CSF, the parental and derivative 32D cells responded in a similar way, too. That is, they differentiated into neutrophils after proliferation for several days (circles). In contrast, these three populations responded to E 2 quite differently (triangles). While E 2 did not support growth of 32D at all (Figure 3a) , this hormone stimulated 32D/⌬Y703F-GCRER to proliferate similarly to IL-3 ( Figure 3c ). When 32D/⌬GCRER cells were stimulated by E 2, they slowly proliferated for a limited period, but eventually they ceased to divide and differentiated into granulocytes (Figure 3b) . Since the growth rates of 32D/⌬GCRER clones were somewhat greater when stimulated by E 2 than G-CSF, ⌬GCRER-mediated signals may not be identical to that of endogenous G-CSFR. Nevertheless, ⌬GCRER transmitted differentiation signals that finally overcame cell growth. In contrast, ⌬Y703F-GCRER-mediated signals were totally different from those of ⌬GCRER and endogenous G-CSFR, eliciting continuous growth with minimal differentiation.
The predominant growth signal mediated via ⌬Y703F-GCRER was confirmed by long-term culture of 32D/⌬Y703F-GCRER. With 10 −7 m E 2 , 32D/⌬Y703F-GCRER proliferated continuously for at least 1 month, and the cells maintained an immature phenotype as shown in Figures 2h and i . In addition, the long-term growth of 32D/⌬Y703F-GCRER was estrogen-dependent and they stopped growing upon E 2 withdrawal ( Figure  4 ). Taken together with the observation that switching from E 2 to G-CSF induced granulocytic differentiation (Figure 2g) , we concluded that the proliferation of 32D/⌬Y703F-GCRER was mediated by E 2 -dependent ⌬Y703F-GCRER activation.
We also transduced Ba/F3, another IL-3-dependent hematopoietic line, with MX/⌬GCRER-IRES-CD8a and MX/⌬Y703F-GCRER-IRES-CD8a retroviruses. Unlike transduced 32D, there was practically no difference in the growth rates between ⌬GCRER-and ⌬Y703F-GCRERtransduced Ba/F3 cells on estrogen treatment (Figure 3d ). Both populations continuously proliferated and no morphological alterations were observed.
Discussion
We have analyzed the functions of modified selective amplifier genes in 32D and Ba/F3 cells. Both cell lines were IL-3-dependent for blastic growth and the former had differentiation potential while the latter did not. When expressed in Ba/F3, all the chimeric receptors (GCRER, ⌬GCRER and ⌬Y703F-GCRER), as well as G-CSFR, transmitted only growth signals with appropriate stimulation. However, different phenotypes were observed in 32D cells expressing ⌬GCRER and ⌬Y703F-GCRER. Estrogen induced granulocytic differentiation in 32D/⌬GCRER similarly to G-CSF, but supported continuous growth of 32D/⌬Y703F-GCRER. The postulated balances of growth and differentiation signals via these molecules are shown schematically in Figure 5 . At least in Ba/F3, ⌬GCRER and ⌬Y703F-GCRER seemed to transmit growth signals with comparable strength. However, a differentiation signal mediated via ⌬GCRER rapidly overcame proliferation in 32D. Y703F mutation diminished the differentiation signal and allowed the transduced 32D cells to proliferate continuously with E 2 .
There is some disagreement over the precise roles of the tyrosine residues in G-CSFR. Yoshikawa et al 12 showed that Y703F mutation in murine G-CSFR stimulated growth but blocked differentiation of the mouse myeloid cell line LGM-1. De Koning et al 21 delivered a Y704F mutant of the human G-CSFR (analogous to murine Y703F) gene into 32DC10, which is similar to 32Dcl3 but lacks an endogenous G-CSFR, and found that the transfected cells underwent granulocytic differentiation with G-CSF. Our results seem to favor a pivotal signaling role of tyrosine-703 in granulocytic differentiation.
To date, strategies for in vivo selection of gene-modified hematopoietic cells have involved drug-resistance genes such as mdr-1. 22 Expansion of the target cells in these systems is a secondary event, relying on the relative toxicity of cytocidal agents to eliminate untransduced cells. We have proposed a novel concept of 'selective amplifier genes' to confer a direct growth advantage on the target cells in response to exogenous stimuli. As a similar system to our GCRER chimeric receptors, Blau et al 23 reported that cytokine receptor-FKBP12 fusion genes conferred inducible proliferation on transfected Ba/F3 cells. 24 Their system involves synthetic dimerizers such as FK1012, of which short half lives and potential interactions with cellular immunophilins may be problematic in clinical use. ⌬Y703F-GCRER is activated by a naturally occurring steroid (E 2 ) with high stability and thus seems to be more practical for in vivo application. In addition, long-term culture and switching (from E 2 to G-CSF) experiments demonstrated that the function of ⌬Y703F-GCRER was under strict control of E 2 and that the unli- ganded ⌬Y703F-GCRER did not disturb G-CSFR signaling. Thus, expression of ⌬Y703F-GCRER in primary hematopoietic cells is unlikely to result in neoplastic growth as the cells will differentiate along their intrinsic programs without estrogen stimulation.
Another concern about the 'selective amplifier gene' system arises from the usage of the wild-type ER-HBD, which can be activated by high-level estrogen in female subjects. To circumvent this problem, we have investigated the feasibility of using a mutant ER, which specifically binds to a synthetic steroid 4-hydroxytamoxifen (Ref. 25 and manuscript in preparation). Those improved selective amplifier genes will serve as more suitable means for practical use in stem cell expansion in vivo.
Materials and methods
Plasmid construction
For murine IL-3 production in cultured cells, pBMG-hph-IL3 was constructed. This plasmid has a Rous sarcoma virus promoter-driven IL-3 cDNA and a hygromycin Bresistance gene (from pY3 plasmid) in the pBMGNeo backbone. [26] [27] [28] [29] Bicistronic mammalian expression vectors
Figure 5 Postulated schema of growth and differentiation signals in the selective amplifier gene-modified hematopoietic cells. G-CSF dimerized G-CSFR and triggered downstream signals for growth and differentiation (left). Binding of estrogen to ER-HBD activated ⌬GCRER and the chimeric receptor transmitted growth and differentiation signals analogous to native G-CSF stimulation (middle). Y703F mutation suppressed the differentiation signal in the chimeric receptor, while the growth signals were transmitted as with ⌬GCRER (right).
were constructed with the pMX retrovirus backbone and the EMCV-derived IRES (nucleotides 259-833 of EMCV-R genome), to ensure cap-independent translation of the neomycin phosphotransferase (neo; cleaved from pRSVneo) or murine CD8a gene as a selectable marker. [15] [16] [17] 30 pMX/MCAT-IRES-neo has the murine ecotropic receptor gene (MCAT-1; a gift from Dr JM Cunningham, Harvard Medical School, Boston, MA, USA) placed upstream of the IRES-neo cassette. 19 pMX/⌬GCRER-IRES-CD8a is a modified vector of pMX-⌬(5-195)GCRER described previously, for coexpression of deleted GCRER and CD8a. 5 pMX/⌬GCRER-IRESCD8a was further modified using a Transformer SiteDirected Mutagenesis Kit (Clontech, Palo Alto, CA, USA), with a mutagenic primer (5Ј-CCCTGGTTCA GGCCTTTGTGCTCCAAGGA GA-3Ј) and a selective primer (5Ј-CTTCC TTTTTCGATATCATTGAAGCATTT-3Ј). The resultant construct was designated as pMX/⌬Y703F-GCRER-IRES-CD8a, with substitution of a phenylalanine for tyrosine in the corresponding position 703 in the murine GCRER.
Cell lines
Ba/F3 (Riken Gene Bank RCB0805, Tsukuba, Japan) and 32Dcl3 cells (a gift from Dr T Suda, Kumamoto University, Kumamoto, Japan) were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS; Bioserum, Victoria, Australia) and 0.5% conditioned medium of C3H10T1/2 cells (Riken Gene Bank RCB0247) transfected with BMG-hph-IL3 as an IL-3 source. Titration studies with 32Dcl3 cells revealed that this dose of the conditioned medium had an equivalent titer to 100 U/ml murine IL-3 (Dr A Okano, Ajinomoto, Yokohama, Japan). PA317 (American Type Culture Collection (ATCC) CRL-9078, Rockville, MD, USA) and BOSC23 (ATCC CRL-11554) packaging lines were maintained in Dulbecco's modified Eagle medium containing 10% FCS.
Retrovirus vector production and transduction PA317 amphotropic packaging cells were transfected with pMX/MCAT-IRES-neo using Lipofectamine (Life Technologies, Grand Island, NY, USA) and the virus supernatant was harvested on day 2 after lipofection to transduce 32Dcl3 cells. Transduction was carried out with a standard protocol; 32Dcl3 cells were incubated in the virus supernatant containing 8 g/ml of polybrene for 2 h, followed by an additional incubation for 22 h in fresh viral supernatant. After transduction, the infected 32Dcl3 cells were selected with 1.5 mg/ml G418 (Life Technologies) and the resistant cells (32D) were pooled for further transduction.
To transduce 32D cells, BOSC23 cells were lipofected with pMX/⌬GCRER-IRES-CD8a and pMX/⌬Y703F-GCRER-IRES-CD8a and viral supernatants were harvested. After transduction by the standard protocol described above, 1 × 10 7 cells were selected using a magnetic cell sorting (MACS) system and an anti-CD8a antibody conjugated with magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). The immunoselected cells were analyzed by a FACScan (Becton Dickinson, San Jose, CA, USA) using a fluorescein isothiocyanate (FITC)-labeled anti-CD8a antibody (Pharmingen, San Diego, CA, USA). CD8a-positive cells were cloned by limiting dilution and the transgene in each isolate was examined by PCR to amplify the 476-bp junctional fragment between G-CSFR and ER-HBD. 5 Another murine hematopoietic line, Ba/F3, was transduced with MX/⌬GCRER-IRES-CD8a and MX/⌬Y703F-GCRER-IRES-CD8a as described above, except that limiting dilution was carried out with 10 −7 m E 2 (Sigma, St Louis, MO, USA) to isolate estrogen-responsive clones.
Morphological characterization and cell proliferation assay Cells were cytospun on to glass slides and stained with Wright-Giemsa for morphological characterization. Short-term cell proliferation assay was performed using a Cell Proliferation Kit II (XTT) (Boehringer Mannheim, Mannheim, Germany). 20 Starting with the cell density at 1 × 10 5 cells/ml, viable cell numbers were estimated by measuring formazan formation from XTT, represented as absorbance difference at 490 nm from 620 nm (A 490 -A 620 ). Parental and transduced 32D cells were incubated with IL-3, 10 ng/ml recombinant human G-CSF (kindly provided by Chugai Pharmaceutical, Tokyo, Japan), or 10 −7 m E 2 . For long-term culture, 32D/⌬Y703F-GCRER cells were maintained with 10 −7 m E 2 and split every 5 days adjusting the cell density to 1 × 10 4 cells/ml. A subset of the long-term cultured cells was periodically removed and transferred to medium without E 2 for XTT assay.
